Supporting our network's growth remains at the heart of what we do. Explore our upcoming learning opportunities and discover how you can continue to develop your skills, connect with others, and stay ahead in the sector.________________________________________________
One Nucleus Training
6-7 May 2026 | Online Introduction to Managing Life Science Projects, Register Here...
This one-day face-to-face training equips new or transitioning project managers and technical staff in life sciences with practical project management skills. It covers the end-to-end project process, key tools,…
LONDON, UK and COPENHAGEN, Denmark – April 22, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for Oral Care AB and is pleased to announce the placement of Lucas Kromann as Chief Executive Officer (CEO) Denmark.Oral Care is a leading dental care service provider offering both clinic-based and mobile dental services across Sweden, Norway, and the Netherlands. Following its acquisition by the Nordic private equity group Axcel in 2022, Oral Care is now…
As a long-standing partner of One Nucleus, Digital Science are committed to providing the Biotech and Pharma community with the tools needed to navigate an increasingly complex data landscape. We are excited to introduce Compass, our newest dedicated application designed to transform how your Medical Affairs and Publication Planning teams measure impact.
For our partners in both emerging biotech and established pharma, the challenge is often the same: navigating "the black hole" of publication tracking. Compass solves this by unifying Dimensions citation data and Altmetric attention…
LONDON, UK – April 16, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search for Babraham Research Campus Ltd (BRCL) and is pleased to announce the placement of Dr. Rich Ferrie as Chief Executive Officer (CEO). Babraham Research Campus is one of the UK’s leading places to support early-stage bioscience enterprise. It is distinct in its co-location of over 60 bioscience companies alongside the Babraham Institute – creating an environment where world class research and business…
Some of the UK’s most ambitious early-stage life science companies are choosing Victoria House as their London base, adding fresh momentum to one of the capital’s most exciting life science communities.
Developed by Oxford Properties and Pioneer Group, the Bloomsbury Square building has attracted 24 innovative organisations since it launched last year, drawn by a rare and unique combination of high-quality incubator labs, flexible workspace, and a genuinely collaborative community.
Among the latest arrivals to Victoria House is Draig Therapeutics, a clinical-stage biopharmaceutical company…
Companies confirm that markers of weight loss and glycemic control are distinct in preliminary study, with multiple mechanisms identified that provide opportunities to guide indication extensionOXFORD, UK and PORTLAND, ME – 15 April 2026 – Ovation.io, a leading human omics and clinical data company, and PrecisionLife, a precision medicine company transforming how complex chronic diseases are understood and managed, today announced that they have reached agreement to commercialize the outputs of PrecisionLife’s analysis of Ovation’s high quality GLP-1 receptor agonist dataset. The…
Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the region
Expands regional capabilities with funding for high-volume local manufacturing, as well as relevant regulatory filings and research collaborations
Strategic partnership enables access to new investment opportunities from Saudi sovereign funds
Newcastle, UK, 15 April 2026: Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has established…
Sandwich, UK — 15 April 2026: International contract research organisation ChemPartner has officially opened its first European scientific hub at Discovery Park, Sandwich, Kent. The company works with the biopharmaceutical industry to efficiently and rapidly bring life-changing drugs to market.
Founded in Shanghai in 2002, ChemPartner has more than 2,000 employees globally, most of whom are based in Asia. The company currently has seven UK employees, many of whom work hybrid, and is actively recruiting for a Senior Scientist to be based at Discovery Park.
ChemPartner’s Discovery Park facility…
ELRIG Announces Inaugural US Drug Discovery Conference
Free-to-attend event takes place at Pfizer in Cambridge, MA from 16–17 June
Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets
Cambridge, UK, 14 April 2026: ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the launch of Drug Discovery USA 2026. The inaugural event, taking place at Pfizer in Cambridge, MA from 16–17 June, offers the drug discovery communities in Europe and the US the…
Amsbio reports how researchers at the Graduate School of Medicine, Kyoto University (Japan) have cultured patient-derived colorectal cancer cells in 3D using their MatriMix 511 extracellular matrix (ECM).
In this study** the researchers demonstrated that MatriMix supported robust cancer organoid formation, and that the organoids retained biologically relevant differences between tumour stages. By comparison, alternative matrices evaluated showed limited or no metastatic marker expression. The researchers concluded that MatriMix offers the ability to…